Orchestra BioMed OBIO
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 4.15 | 96.38 | 0.26 | 6,754 | 6 | |
| 2025Q3 | 2.48 | -0.38 | -20,313 | -21 | ||
| 2025Q2 | 2.68 | 99.15 | -0.50 | -19,327 | -19 | |
| 2025Q1 | 4.28 | 100.89 | -0.49 | -18,921 | -19 | |
| 2024Q4 | 4.00 | 125.19 | -0.43 | -16,677 | -16 | |
| 2024Q3 | 5.14 | 105.94 | -0.41 | -16,342 | -15 | |
| 2024Q2 | 8.15 | 105.50 | -0.44 | -16,859 | -16 | |
| 2024Q1 | 5.27 | 107.13 | -0.38 | -14,423 | -13 | |
| 2023Q4 | 9.13 | 97.37 | -0.37 | -12,481 | -13 | |
| 2023Q3 | 8.72 | 90.45 | -0.37 | -14,524 | -13 | |
| 2023Q2 | 7.00 | 93.40 | -0.34 | -12,956 | -12 | |
| 2023Q1 | 19.57 | 97.63 | -0.40 | -11,545 | -11 | |
| 2022Q4 | 9.98 | -0.44 | -877 | -1 | ||
| 2022Q3 | 9.90 | 97.31 | -1.06 | -10,067 | -10 | |
| 2022Q2 | 9.96 | 100.43 | -0.12 | -7,634 | -8 | |
| 2022Q1 | 9.91 | 93.36 | -0.62 | -5,128 | -6 | |
| 2021Q4 | 10.08 | -0.01 |